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ABSTRACT 
 
Non-invasive prenatal testing (NIPT) is an emerging form of prenatal genetic testing that 
provides information about the genetic constitution of a foetus without the risk of pregnancy 
loss as a direct result of the test procedure. As with other prenatal tests, NIPT can help to 
make a decision about termination of pregnancy, plan contingencies for birth or prepare to 
raise a child with a genetic condition. NIPT can also be used by women and couples to test 
purely ‘for information’. Here, no particular action is envisaged following the test; it is 
instead entirely motivated by an interest in the result. The fact that NIPT can be performed 
without posing a risk to the pregnancy could give rise to an increase in such requests. In this 
paper, we examine the ethical aspects of using NIPT ‘purely for information,’ including the 
competing interests of the prospective parents and the future child, and the acceptability of 
testing for ‘frivolous’ reasons. Drawing on several clinical scenarios, we claim that arguments 
about testing children for genetic conditions are relevant to this debate. In addition, we raise 
ethical concerns over the potential for objectification of the child. We conclude that, in most 
2 
cases, using NIPT to test for adult-onset conditions, carrier status or non-serious traits 
presenting in childhood would be unacceptable.  
 
 
 
INTRODUCTION 
 
For better or worse, the availability of prenatal screening and testing has undoubtedly 
increased the choices available to women and couples. Women may choose to access a 
prenatal test to determine the course of the pregnancy, to prepare for a safe birth or to 
adjust to the prospect of parenting a child who has or who will develop a genetic condition. 
The prenatal testing landscape has recently been changed by the development of non-
invasive prenatal testing (NIPT), a new method of obtaining foetal DNA for analysis. A 
notable advantage of NIPT is that, unlike current prenatal diagnosis (PND), the test itself does 
not carry a risk of miscarriage. 
 
NIPT is not yet as robust and reliable as ‘traditional’ methods of prenatal diagnosis (PND), 
such as amniocentesis and chorionic villus sampling. This means that it is still often regarded 
as only an “advanced screening” method, whether offered in a screening programme or as a 
stand-alone test.1 However it is already possible to use NIPT to test for many of the same 
single-gene and chromosomal genetic conditions as PND; be it for a serious medical 
condition that presents in childhood, a serious medical condition that presents in adulthood, 
a non-serious medical condition or carrier status.2 There has been considerable success in 
developing NIPT for a range of conditions and traits such as haemophilia, sex determination 
and trisomy 21. Complete sequencing of the foetal genome has also been achieved in a 
research setting.3 Although it remains a challenge, this paper rests on the assumption that 
NIPT can be used to interrogate the foetal genome in just the same way as with an invasive 
test. 
 
The wider ethical, legal and social implications of NIPT have been discussed elsewhere.4  
However, one of the most striking possible implications of NIPT has not yet been addressed. 
Women and couples choose prenatal screening or testing for a variety of reasons, including 
determining whether to continue or terminate a pregnancy, or to increase their knowledge 
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of their foetus with no intention to terminate. Because of the risk of miscarriage associated 
with invasive tests (around 1% depending on the test and its timing5), until now couples have 
been encouraged to consider the risk to the foetus of any invasive procedure when deciding 
about prenatal screening or testing. If this ‘barrier’ of risk to the foetus is removed, the 
uptake of testing in pregnancy (including requests for testing ‘purely for information’, with 
no intention to terminate) might well be higher. 
 
We are interested in the ethical implications of the use of NIPT ‘purely for information.’ An 
interested couple may have a desire to undergo NIPT much in the same way that some 
people find out the sex of their foetus in utero through ultrasound scanning; not with the 
intention to detect a range of abnormalities, but to obtain information about the 
characteristics of the foetus, perhaps to help them bond with their baby, or simply to satisfy 
their curiosity. This use of NIPT ‘for information only’ might arise in both individual requests 
for testing or an organised screening programme. 
 
The paper is divided into four sections. Section I introduces five clinical scenarios to describe 
possible uses of NIPT for information only. In Section II we give an account of the main 
arguments about genetic testing in children, which we then apply to prenatal testing in 
Section III. In Section IV we ask how, if at all, the introduction of the non-invasive aspect of 
testing affects the debate. We suggest that the most notable difference between using 
childhood or invasive prenatal testing for information only and using NIPT for information 
only is that NIPT may give rise to testing for ‘frivolous’ reasons, something that may be 
objectionable not because of its potential for harm, but because it may encourage the 
objectification of children.  
 
SECTION I. CLINICAL SCENARIOS 
 
To illustrate how the issue of using NIPT ‘purely for information’ may arise in practice, we 
have outlined five clinical scenarios. Each involves a planned pregnancy. 
 
(i) Requesting a test for carrier status 
Ms A is pregnant and is a known but unaffected carrier of the cystic fibrosis gene 
change. No gene change has been able to be identified in her partner, so their foetus 
is at low risk of being born with this condition. However Ms A is very interested to 
know whether the foetus also carries her gene change, even though she will not take 
any action based on this information. 
 
(ii) Requesting a test for a minor genetic condition 
Ms B is pregnant and has a genetic condition which carries no health implications but 
for shorter than normal height. A gene change causing this condition is known. Ms B 
wishes to know whether her foetus also has this gene change but she wishes to 
continue the pregnancy whatever the result. 
 
(ii) Requesting a test for foetal sex 
Ms C and her partner are in the early stages of pregnancy. They are very excited to 
be pregnant after experiencing three miscarriages. They are intrigued to know the 
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sex of their foetus and don’t wish to wait for a mid-pregnancy ultrasound to find out. 
They don’t have a preference for a particular sex. 
 
(iv) Requesting a test for a serious adult-onset condition 
Ms D is pregnant, and her partner has the gene change that will lead to Huntington’s 
disease (HD; an adult-onset neurodegenerative disorder), although he is currently 
symptom-free. Given their experiences, such as caring for a recently deceased 
relative who had HD, they would like to know whether their foetus has the HD gene 
change so that they could prepare themselves, and their child, for the future. They 
have no plans to terminate the pregnancy. 
 
(v) Offering foetal whole genome sequencing 
Ms E is pregnant with her first child. Her maternity care provider is linked to a 
research institute that has recently commenced a trial of foetal whole genome 
screening for any pregnant woman regardless of medical history. The trial involves 
analysing the whole genome of the foetus, using material obtained via NIPT. Results 
will provide information about all known conditions and traits. Ms E would like to 
participate in this trial to obtain this information. She would like to know more about 
her foetus, but plans to continue the pregnancy whatever the tests reveal. 
 
In many instances of prenatal diagnosis or screening, a request for testing ‘for information 
only’ (with no intention to terminate) would be relatively uncontroversial because there may 
be medical benefits such as managing pregnancy or birth, or providing the newborn with 
treatment that could be balanced against the risk of miscarriage. Making a test available by 
NIPT is therefore an unalloyed benefit in these kinds of circumstances. However in scenarios 
such as those described above, those requesting testing may be counselled against invasive 
testing as it would offer no prospect of medical intervention for a cure or alleviation of 
symptoms but risked the pregnancy. NIPT will alleviate this risk – does this make these kinds 
of prenatal tests defensible? Or is the converse instead true, that the ability to perform a test 
without risk is in fact something of a disadvantage as it is more likely to generate ethical 
difficulties and conflicts? 
 
In the analysis that follows, we recognise that there is no way of really knowing why a 
woman or couple will opt for a test; whether it be ‘for information only’, to inform a decision 
to terminate or continue with pregnancy.6 It is also possible that a person embarking on a 
test purely to gain information might change her mind about continuing the pregnancy on 
the basis of the results, especially if a serious genetic condition is revealed. For the purposes 
of this paper we are basing the option of testing ‘purely for information’ on expressed 
preferences at the time of testing. We acknowledge that generating information about a 
foetus can only ever be said definitely to have been 'for information only' with the benefit of 
hindsight. However there is always a chance that a woman may choose to end a pregnancy, 
for a variety of reasons. 
 
This possible difference between expressed and actual preferences might also have further 
moral implications, such as an increase in rates of termination. Thus the real-world scenarios 
are likely to be more complex than we have described them above. Nevertheless these 
scenarios are helpful to isolate and address the moral questions about testing purely for 
information. 
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Some brief comments can also be made on the above scenarios. For example, unexpected 
results could arise from these tests (e.g. a lethal impairment or intersex status), potentially 
causing distress, and maybe also leading to a decision to terminate.7 Also, taking the whole 
genome sequencing scenario (v), would testing purely ‘for information’ be acceptable given 
that the information gained will be of less importance than with the ‘adult onset condition’ 
case (iv)? At least at the present, the ability to interpret genome wide datasets in relation to 
future health and the modification of lifestyle is limited, so that the harm they might cause 
may also be limited. However, the ability to interpret such data will doubtless improve. It 
would also be possible for parents to attach too much significance to the results. In the 
section that follows we turn to the debate surrounding genetic testing in children, which 
provides a partial answer to these questions. 
 
SECTION II. SYNTHESISING THE ETHICAL DEBATE OVER GENETIC TESTING IN CHILDREN 
 
In many ways, testing a foetus ‘purely for information’ (whether in a screening or testing 
context) is based on similar principles to carrying out genetic tests on children and most of 
the arguments about the acceptability of testing children (at least those who lack capacity) 
will apply. In this section we briefly outline the relevant points, which relate to the child’s 
interests and privacy. This will then allow us to discuss the questions that remain about 
prenatal testing, and then non-invasive prenatal testing. 
 
The most salient factor in the debate about childhood genetic testing is whether the 
condition is a) childhood-affecting or b) adult-onset. 
 
a) Childhood-affecting conditions 
Perhaps the most compelling reason to test a child for a certain genetic condition is the 
interests of the child, which are usually considered paramount. There is a large literature 
about whether testing is in a child’s best interests.8 It is thought that, if they know their 
child’s genetic status, parents may be better able to adapt psychologically to bringing up a 
child with a certain genetic condition and will be more supportive and nurturing parents as a 
result. Following testing, parents may also be better able to put in place social, practical and 
financial arrangements for care of their child, and the child can prepare him/herself 
psychologically for the onset and development of that condition. When a negative (no gene 
change identified) result is given, parents and their child may be less anxious about the 
child’s future, and need not make unnecessary financial and social contingency plans.9 
However, if a gene change is identified there may also be increased anxiety for all concerned 
of watching a child for early signs of the condition in the family, or over-interpreting possible 
early signs that may not manifest. 
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b) Adult-onset conditions 
Where a genetic test in a child is not diagnostic but predictive of adult health, a similar 
interests-focussed discussion may be had. Here the interests under consideration are those 
of the future adult whom the child will become. For example, parents may be able to prepare 
their child psychologically or financially for a future with a certain condition. Conversely, they 
may also limit their child’s future – to the detriment of the child – by failing to set up 
provision for their child’s adulthood. 
 
Notwithstanding this debate, finding out facts about an individual’s adult future is also often 
considered inappropriate as it delves into their (future) private sphere. Invading a competent 
adult’s privacy in order to improve their welfare is to exercise hard paternalism and is rarely 
justifiable. It may be thought that, since the individual being tested is a child at the time, 
decisions about that child’s interests rest with her parents or guardians, and that it is merely 
soft paternalism, which is deemed more justifiable (and perhaps even a duty). Indeed, 
parents often act against their children’s wishes in order to secure their future welfare as 
adults (for example by insisting on school attendance and instilling healthy eating habits). But 
we suggest there is good reason to think that testing children for adult-onset conditions 
would be to exercise hard paternalism. There are important differences between the 
arguments for testing for adult-onset conditions and other accepted interventions during 
childhood.  
 
First, paternalistic actions such as insisting on education and healthy eating habits usually 
have short-term benefits for the child as well as long-term benefits for the future adult. 
There are no short-term benefits either to a child knowing she will (or is very likely to) 
develop an adult-onset genetic condition or to the parents knowing this.  
 
Second, childhood is the most appropriate stage of development for some skills, knowledge, 
character traits and so on (e.g. healthy eating habits), but is not the most appropriate stage 
for others (e.g. forming sexual relationships). This can be termed a principle of identifying the 
most appropriate life-stage for an action or intervention. For childhood genetic testing for 
adult-onset conditions, testing for most could not be justified at the life stage of a child. 
There are some genetic conditions for which effects can be lessened by early measures, such 
as having regular colonoscopies to identify early stages of bowel cancer in familial 
adenomatous polyposis coli (FAP). However there only a few such conditions. 
 
Third, there is a distinction between an action that widens an individual’s future choices and 
an action that narrows them down. For example, in insisting on a child’s education, a parent 
is increasing the future adult’s choices for further education, employment and participation 
in community life. In testing a child for an adult-onset condition, the parents are narrowing 
her options, at least because the (future) adult cannot change the past and choose for her 
parents not to know her results.  
 
In addition, if her parents tell her the results, she also cannot choose not to know herself. In 
this way, testing could also be said to violate the child’s ‘open future’10 to decide for herself 
what tests to have.  Having information about an adult-onset condition may be harmful to 
the child. Rather than feeling psychologically prepared, the child may feel greater anxiety 
knowing she faces a future with a particular condition. It has also been suggested that, if 
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results were negative, the child may still experience anxiety.11 Parents may project unrealistic 
or unfair expectations onto their child, with harmful effect, and the child may find herself 
stigmatised, or her behaviour given a medical label inappropriately. 
 
Thus, unlike testing for conditions that usually affect children, it is arguable that knowledge 
about a person’s adult onset conditions is exclusively the business of the at-risk individual, 
not her parents. Parents who access personal information relevant to the adult their child 
will become are arguably invading her future privacy. Similarly, healthcare professionals who 
divulge information to parents about their future adult child are breaching confidentiality. 
Therefore there needs to be good justification for accessing and revealing personal facts 
about another (future) adult. This position is reflected in clinical practice12 and professional 
guidance about predictive genetic testing in children.13  
 
SECTION III. PRENATAL TESTING 
 
When the individual being tested is a foetus, rather than a child, the reasoning would appear 
to be identical unless the question arises of possibly terminating the pregnancy. Termination 
does not arise in the instance under discussion here, as we are considering testing ‘purely for 
information’ (albeit subject to the limitations identified in Section I above). Therefore, if a 
woman or couple intend to continue the pregnancy regardless of the result, most of the 
points we have made in relation to genetic testing in children can be applied to testing a 
foetus. The same considerations about interests and privacy apply.  
 
What is strikingly different between a child and foetus, however, is the status of the being 
whose future interests are being evaluated. In many jurisdictions, the foetus does not have 
the legal status of a child. The moral status of the foetus is less obvious and, indeed, hotly 
disputed. Any argument against testing a foetus for information for the sake of that being (as 
we have done above with testing children) would have to rely either on the foetus having 
rights and interests at the time of being a foetus, or on the claim that the future child or 
adult has interests that ought to be safeguarded in advance.  
 
We will not explore the question of whether a foetus has rights and interests at the time of 
being a foetus because this issue has been discussed extensively in the context of 
termination of pregnancy.14 We also do not rest our position on the moral status of the 
foetus, as will be explained below. We do assume that a foetus does not have sufficient 
rights to override those of the prospective parents in circumstances of prenatal testing, but 
despite this the interests and rights of the future being remain relevant and could potentially 
override the rights of the prospective parents to access information. 
 
As we have discussed above, when considering testing children for adult-onset conditions, it 
is fairly well accepted that the future adults’ interests should be safeguarded. In the case of a 
continuing pregnancy, the foetus is a future person, just as a child is a future adult. Duncan et 
al claim that, because the foetus is within the womb and therefore part of the woman, the 
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woman has the right to information about the foetus.15 They claim that a woman does not 
lose her right to information simply because she wishes to continue her pregnancy. While 
this line of argument is convincing in termination cases, it cannot be applied with the same 
force in the case of testing for information only, simply because it is expected that there will 
be an individual resulting from the pregnancy. Thus, the moral rights of the potential future 
adult are in competition with the pregnant woman’s. It is also something of an illusion to 
think that the woman wants to know that her foetus does not have an adult-onset disorder. 
In fact, the woman wants to know that the future adult will not have the disorder. 
 
Although in many jurisdictions the foetus does not have the legal status of a child, in cases in 
which a decision has been made to continue pregnancy, it is likely (all being well) to be on 
the same path to adulthood as an existing child. Thus, any argument for not testing a child in 
order to protect the privacy of the future adult also applies to not testing a foetus in a 
continuing pregnancy.  This is to protect the interests and privacy of the future adult. As it is 
the future adult whose interests one is trying to preserve, it could be argued that it makes 
little difference when the act of gathering the information takes place. As Delatycki states: 
 
“If the ethical consequences dictate that it is preferable not to offer … [a test for 
Huntington’s] the fact that the test is prenatal rather than being a test on an 
individual outside the womb does not make it any more justifiable.”16 
 
If our claim that predictive genetic testing in children is usually inappropriate can be 
supported, and our claim that a foetus in utero in a continuing pregnancy will be subject to 
the same considerations, then it would appear that testing a foetus ‘purely for information’ 
will not always be appropriate. Clinical scenarios (i – carrier testing), (iv – testing for an adult 
onset condition), and (v – whole genome sequencing) may be deemed inappropriate on this 
reasoning; while scenarios (ii – testing for a minor condition) and (iii – testing for sex) will 
require further analysis. 
 
SECTION IV. (HOW) DOES THE NON-INVASIVE ASPECT OF NIPT MAKE IT MORE ACCEPTABLE 
TO TEST FOR INFORMATION ONLY? 
 
When considering prenatal testing ‘purely for information,’ the most important clinical 
difference between invasive and non-invasive testing is the lack of risk. In this section we 
explain how this difference may affect the debate on testing foetuses for information only.  
 
As mentioned above, NIPT poses no medical risk to the viability of a pregnancy. Opening up 
access to NIPT may therefor increase the overall uptake of NIPT and may attract those whose 
reluctance to test purely for information had been due solely to the risk of miscarriage. In 
clinical scenario (v), involving Ms E considering whole genome sequencing for her foetus, this 
might include non-health traits, such as muscle fibre types associated with athletic ability. 
Such tests might pejoratively be termed ‘frivolous,’ given that they are motivated by a mere 
interest in the information rather than for medical reasons. 
 
In this context, we take ‘frivolous’ testing to mean testing that is motivated by values that are 
not worthy of being taken seriously. However we recognise that this needs further 
qualification in order to be meaningful in practise. At their extremes, the notions of frivolous 
and non-frivolous will be universally (though not comprehensively) shared. For example, 
using NIPT to detect foetal rhesus status to detect risk of haemolytic disease of the newborn 
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(preventable via administering anti-D to the pregnant woman) is a good candidate for a non-
frivolous reason. As a comparator, clinical scenario (ii), involving testing for a condition that 
only indicated height, purely for information, would be harder to defend; why would this 
information be needed in pregnancy? Nevertheless, there are traits and motivations that lie 
between these extremes (perhaps such as clinical scenario (iii) involving sex testing), and 
frivolity is subjective. Drawing the boundaries between those values to be taken seriously 
and those that should not be is a challenging task, and we will not attempt it here. Rather, 
we raise this as a moral principle by which access to NIPT purely for information could be 
allowed or restricted. 
 
For minor conditions or traits, removing the risk of prenatal testing may open up a host of 
possibilities for testing out of curiosity; as several of the clinical scenarios in Section I suggest. 
On the other hand, the potential impact of the results for serious conditions (such as clinical 
scenarios (iv) or (v)) has not changed. NIPT may be disproportionately easy to undergo given 
the potential impact of the results. Therefore, when making a judgement about whether 
testing a foetus is acceptable, we should recognise that ‘frivolous’ testing might be in higher 
demand once the technology is simplified. Testing for serious childhood conditions will still 
entail a careful weighing of the potential benefits and harms, with only one of the potential 
harms (miscarriage) removed.  
 
Thus far we have largely focused on concerns about interests or the preservation of privacy 
for the future adult. There remains a more subtle objection to some prenatal testing, one 
which recognises a certain loss of humanity or respect for persons. This is that ‘unnecessary’ 
testing in pregnancy may be regarded as troubling is that it may objectify the foetus and 
resulting child. By making an effort to reveal certain traits, the expectant parents in several of 
the above clinical scenarios would be showing an inappropriately motivated interest in those 
traits, and in doing so would be expressing their views about what they valued. That 
expectant parents could value a non-serious characteristic of their foetus this much is, to 
some, distasteful.  
 
A helpful approach might be to consider that of the ‘virtuous’ parent17 or perhaps a ‘virtuous 
counsellor.’ While a detailed analysis of this concept is beyond the scope of this paper, 
relevant questions relate to the kind of parents that women and couples should aim to 
become (or the kind of professional someone practising in this area should be), what 
information couples require in order to be at least a ‘good (enough)’ parent, and what 
information is not required and might even be regarded as excessively intrusive? From a 
virtue-oriented perspective, there is no reason to distinguish actions of a parent or 
professional towards a future child from those towards a young child. There is no need to 
generate unhelpful information in the short term if that information might lead to harm or 
an invasion of privacy of the future child or adult. It is difficult to see any justification for 
generating such 'trivial' information from this perspective. 
 
Considering the clinical scenarios in Section I, if a woman or couple elected to have NIPT to 
test for carrier status (scenario (i)), stature (scenario (ii)), or everything (scenario (v)), she 
may be putting undue value on this information and demonstrating a distasteful degree of 
interest in her future child’s genome. Testing out of curiosity does not itself seem to be 
particularly morally problematic (for example the incidental indication of sex during medical 
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ultrasound)18 but it may seem distasteful to test for certain traits. Doing so is not harmful in 
itself, but it may be an expression or indication of an attitude that is not in keeping with a 
parent who values his or her child for who that child is, not the traits it will have. 
 
The clinical scenario that is less obvious to make a determination on is Scenario (iii), involving 
sex identification in early pregnancy. NIPT for foetal sex is already available and is used 
‘purely for information’ by people like Ms C and her partner. In genuine cases of ‘information 
only’ this is fairly trivial information and could be said to be analogous to determination of 
sex via ultrasound (which many parents opt to do).19  
 
Finally, the wider context of this kind of testing should not be overlooked. For example, 
legitimate questions remain as to how such testing would be funded, and who would have 
access to it. Testing for non-medical traits using NIPT is likely to be considered outside the 
remit of either private health insurance or a state-funded health service, possibly rendering 
this kind of testing a luxury only for those who can afford it. If a state-funded health care 
system did fund such tests, this would presumably be costly, and could further stretch scarce 
resources (such as access to genetic counsellors).20 The justice of offering NIPT for 
information, particularly if an offer of testing is made in the context of a screening 
programme, also raises issues around the responsibility of health professionals (such as 
genetic counsellors) to help ensure that any screening programs incorporating NIPT target 
serious conditions and do not impinge on a child’s right to an open future.  
 
CONCLUSION  
 
We began this paper by posing the question of whether it is ethically acceptable to use NIPT 
to perform genetic tests on a foetus when the purpose of that test is purely to gain 
information about the foetus and not to seek a termination of pregnancy. We have made the 
case that a consideration of interests and privacy applies equally to children and foetuses, 
since they are on the same trajectory to adulthood, and that the same boundaries for testing 
children should apply for prenatal testing ‘purely for information’. 
 
Unlike invasive testing, NIPT has the potential to allow prenatal testing for information 
without the critical drawback of risk of miscarriage. Healthcare professionals and prospective 
parents should recognise that the removal of risk would not make the results any less 
significant, and they should regard a prenatal test as seriously as they would a test during 
 
                                               
18 What counts as ‘frivolous’ varies between cultures and individuals. Sex determination, for example, 
is not a mere curiosity in many cultures. Foetal sex determination is illegal in some jurisdictions 
because such information is frequently abused, and is leading to major shifts in sex ratios: Manchanda 
S, Saikia B, Gupta N, et al. Sex ratio at birth in India, its relation to birth order, sex of previous children 
and use of indigenous medicine. PLoS One 2011; 6(6): e20097. 
19
 This is a good example of a case in which testing ‘for information only’ may lead to action on the 
basis of information, and to wider socially damaging consequences. While this use of NIPT may appear 
innocuous, we should also be mindful that it could greatly exacerbate discrimination against women in 
misogynistic societies if it were to lead to termination of pregnancies of female fetuses. This must be 
tackled at the global level as there is a global market in such technologies. While foetal sex testing is 
(usually) non-medical it is also clearly not always trivial in its consequences. To this end, in reflecting 
on the use of NIPT ‘purely for information’, we should also be mindful of the larger context in which 
this technology operates and consider whether apparently trivial traits may lead to wider socially 
damaging  consequences when incorporated into NIPT. 
20
 With thanks to two anonymous reviewers for this point. 
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childhood, whether the test is requested or offered as part of a screening programme. A 
second effect of the removal of the risk of miscarriage is that there will be one fewer reason 
against testing for what we have termed ‘frivolous’ traits. The remaining objections to 
allowing testing for such traits are that it objectifies the foetus and future child and is not 
part of a virtuous parent’s conduct.  
 
The claims we have made in this paper can perhaps be drawn together under a consideration 
of the kinds of parents that women and couples should aim to become. Those seeking NIPT 
purely for information, such as those described in Section I, should be encouraged to reflect 
on their motivations for such a request and the impact this information may have on their 
pregnancy and child once it is born. We may not yet have precise ‘informational 
expectations’ that could be said to be reasonable to have in pregnancy, but we suggest that 
the information that is necessary to fulfil this expectation may not be as voluminous as we 
might initially think. 
